We are live on
!
Find out more
CIC
Carnegie Investment Counsel Portfolio holdings
AUM
$4.99B
1-Year Est. Return
23.08%
This Fund
S&P 500
This Quarter
Est. Return
+8.51%
1 Year Est. Return
+23.08%
3 Year Est. Return
+101.05%
5 Year Est. Return
+118.22%
10 Year Est. Return
+474.28%
AUM
$2.65B
AUM Growth
+$265M
(+11%)
Cap. Flow
+$82.9M
Cap. Flow
% of AUM
3.13%
Top 10 Holdings %
Top 10 Hldgs %
21.22%
Holding
487
New
33
Increased
237
Reduced
139
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MUDS
Mudrick Capital Acquisition Corporation II Class A Common Stock
MUDS
|
+$10.3M |
| 2 |
Shoals Technologies Group
SHLS
|
+$6.57M |
| 3 |
Array Technologies
ARRY
|
+$5.42M |
| 4 |
Guardant Health
GH
|
+$4.63M |
| 5 |
BSCP
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
|
+$4.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BSCL
Invesco BulletShares 2021 Corporate Bond ETF
BSCL
|
+$7.42M |
| 2 |
Carvana
CVNA
|
+$6.06M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$3.47M |
| 4 |
Beyond Meat
BYND
|
+$3.14M |
| 5 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$2.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 13.39% |
| 3 | Healthcare | 10.89% |
| 4 | Industrials | 9.73% |
| 5 | Consumer Discretionary | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
ARK Genomic Revolution ETF
ARKG
$1.79B
| $1.73M | 0.07% |
18,648
+2,727
| +17% | +$232K |
|
202
TSMC
TSM
$2.19T
| $1.73M | 0.07% |
14,355
-780
| -5% | -$91.4K |
|
203
T-Mobile US
TMUS
$192B
| $1.72M | 0.06% |
11,879
+1,670
| +16% | +$230K |
|
204
Tesla
TSLA
$1.31T
| $1.71M | 0.06% |
7,557
+357
| +5% | +$77.5K |
|
205
Danaher
DHR
$146B
| $1.69M | 0.06% |
7,104
+609
| +9% | +$135K |
|
206
PPG Industries
PPG
$25.8B
| $1.68M | 0.06% |
9,893
+135
| +1% | +$23.2K |
|
207
Vanguard High Dividend Yield ETF
VYM
$83.8B
| $1.67M | 0.06% |
15,916
-64
| -0.4% | -$6.72K |
|
208
Clorox
CLX
$13.1B
| $1.66M | 0.06% |
9,247
-20
| -0.2% | -$3.65K |
|
209
iShares MSCI Emerging Markets ETF
EEM
$29.9B
| $1.66M | 0.06% |
30,050
-130
| -0.4% | -$7.06K |
|
210
Intercontinental Exchange
ICE
$84.9B
| $1.66M | 0.06% |
13,950
| – | – |
|
211
CDW
CDW
$16.9B
| $1.65M | 0.06% |
9,417
-1,720
| -15% | -$296K |
|
212
Deere & Co
DE
$167B
| $1.64M | 0.06% |
4,648
+410
| +10% | +$150K |
|
213
Cleveland-Cliffs
CLF
$7.08B
| $1.64M | 0.06% |
75,835
-7,900
| -9% | -$156K |
|
214
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.78B
| $1.6M | 0.06% |
22,830
-895
| -4% | -$60.9K |
|
215
Huntington Ingalls Industries
HII
$12.9B
| $1.56M | 0.06% |
7,416
| – | – |
|
216
General Dynamics
GD
$106B
| $1.52M | 0.06% |
8,083
+556
| +7% | +$105K |
|
217
Paychex
PAYX
$43.1B
| $1.5M | 0.06% |
13,975
-54
| -0.4% | -$5.43K |
|
218
Amplify Cybersecurity ETF
HACK
$3B
| $1.49M | 0.06% |
24,541
+1,002
| +4% | +$58.3K |
|
219
iShares US Medical Devices ETF
IHI
$3.47B
| $1.48M | 0.06% |
24,630
+4,146
| +20% | +$240K |
|
220
iShares Global Tech ETF
IXN
$9.2B
| $1.48M | 0.06% |
26,328
| – | – |
|
221
Pacific Biosciences
PACB
$354M
| $1.47M | 0.06% |
42,022
+6,600
| +19% | +$192K |
|
222
Eli Lilly
LLY
$1.08T
| $1.44M | 0.05% |
6,256
+255
| +4% | +$51.2K |
|
|
BSMO
223
DELISTED
Invesco BulletShares 2024 Municipal Bond ETF
BSMO
| $1.44M | 0.05% |
55,668
+7,968
| +17% | +$206K |
|
224
Digital Realty Trust
DLR
$70.6B
| $1.43M | 0.05% |
9,508
-963
| -9% | -$146K |
|
225
Duke Energy
DUK
$96.1B
| $1.4M | 0.05% |
14,229
-64
| -0.4% | -$6.43K |
|
Similar funds
MA
SNT
AM
SGM
PAMP
BCM
NL
O
Carnegie Investment Counsel's Q2 2021 Portfolio in Review
As of Q2 2021, Carnegie Investment Counsel held 487 positions worth $2.65B, up 11% from $2.39B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Carnegie Investment Counsel deployed $82.9M of net new capital in Q2 2021, opening 33 new positions and adding to 237 existing holdings. Its largest new stake was Mudrick Capital Acquisition Corporation II Class A Common Stock: 792,400 shares worth $9.87M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco BulletShares 2021 Corporate Bond ETF, an estimated $7.42M trimmed.
- Carnegie Investment Counsel's largest Q2 2021 buy was Mudrick Capital Acquisition Corporation II Class A Common Stock: 792,400 shares worth $9.87M.
- Carnegie Investment Counsel added most to Array Technologies in Q2 2021, an estimated $5.42M increase.
- Carnegie Investment Counsel's biggest Q2 2021 reduction was Invesco BulletShares 2021 Corporate Bond ETF, cutting an estimated $7.42M.
- Carnegie Investment Counsel fully exited PRA Health Sciences, Inc. in Q2 2021, selling an estimated $2.99M.
- Carnegie Investment Counsel's ten largest holdings make up 21% of its $2.65B portfolio in Q2 2021.
- Carnegie Investment Counsel opened 33 new positions and closed 15 in Q2 2021.
- Carnegie Investment Counsel's portfolio value rose 11% quarter-over-quarter to $2.65B.
Based on Carnegie Investment Counsel's 13F filing for Q2 2021, filed 16 Jul 2021.